BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

332 related articles for article (PubMed ID: 36531997)

  • 1. Alternative pre-mRNA splicing as a mechanism for terminating Toll-like Receptor signaling.
    Lee FFY; Alper S
    Front Immunol; 2022; 13():1023567. PubMed ID: 36531997
    [TBL] [Abstract][Full Text] [Related]  

  • 2. NF-κB mediates lipopolysaccharide-induced alternative pre-mRNA splicing of
    Lee FF; Davidson K; Harris C; McClendon J; Janssen WJ; Alper S
    J Biol Chem; 2020 May; 295(18):6236-6248. PubMed ID: 32179652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Alternative pre-mRNA splicing of Toll-like receptor signaling components in peripheral blood mononuclear cells from patients with ARDS.
    Blumhagen RZ; Hedin BR; Malcolm KC; Burnham EL; Moss M; Abraham E; Huie TJ; Nick JA; Fingerlin TE; Alper S
    Am J Physiol Lung Cell Mol Physiol; 2017 Nov; 313(5):L930-L939. PubMed ID: 28775099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. RNA Binding Proteins that Mediate LPS-induced Alternative Splicing of the MyD88 Innate Immune Regulator.
    Lee FFY; Harris C; Alper S
    J Mol Biol; 2024 Apr; 436(8):168497. PubMed ID: 38369277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation of toll-like receptor signaling by the SF3a mRNA splicing complex.
    O'Connor BP; Danhorn T; De Arras L; Flatley BR; Marcus RA; Farias-Hesson E; Leach SM; Alper S
    PLoS Genet; 2015 Feb; 11(2):e1004932. PubMed ID: 25658809
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limiting of the innate immune response by SF3A-dependent control of MyD88 alternative mRNA splicing.
    De Arras L; Alper S
    PLoS Genet; 2013 Oct; 9(10):e1003855. PubMed ID: 24204290
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative Pre-mRNA Splicing in Mammals and Teleost Fish: A Effective Strategy for the Regulation of Immune Responses Against Pathogen Infection.
    Chang MX; Zhang J
    Int J Mol Sci; 2017 Jul; 18(7):. PubMed ID: 28714877
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Essential roles of S100A10 in Toll-like receptor signaling and immunity to infection.
    Lou Y; Han M; Liu H; Niu Y; Liang Y; Guo J; Zhang W; Wang H
    Cell Mol Immunol; 2020 Oct; 17(10):1053-1062. PubMed ID: 31467414
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TRIF-dependent TLR signaling, its functions in host defense and inflammation, and its potential as a therapeutic target.
    Ullah MO; Sweet MJ; Mansell A; Kellie S; Kobe B
    J Leukoc Biol; 2016 Jul; 100(1):27-45. PubMed ID: 27162325
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Toll-like receptor 4-, 7-, and 8-activated myeloid cells from patients with X-linked agammaglobulinemia produce enhanced inflammatory cytokines.
    Marron TU; Martinez-Gallo M; Yu JE; Cunningham-Rundles C
    J Allergy Clin Immunol; 2012 Jan; 129(1):184-90.e1-4. PubMed ID: 22088613
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protein phosphatases in TLR signaling.
    Seumen CHT; Grimm TM; Hauck CR
    Cell Commun Signal; 2021 Apr; 19(1):45. PubMed ID: 33882943
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combined CpG and poly I:C stimulation of monocytes results in unique signaling activation not observed with the individual ligands.
    Arsenault RJ; Kogut MH; He H
    Cell Signal; 2013 Nov; 25(11):2246-54. PubMed ID: 23876795
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer-Associated Perturbations in Alternative Pre-messenger RNA Splicing.
    Shkreta L; Bell B; Revil T; Venables JP; Prinos P; Elela SA; Chabot B
    Cancer Treat Res; 2013; 158():41-94. PubMed ID: 24222354
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The implications of alternative pre-mRNA splicing in cell signal transduction.
    Choi S; Cho N; Kim KK
    Exp Mol Med; 2023 Apr; 55(4):755-766. PubMed ID: 37009804
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Absence of Non-Canonical, Inhibitory
    Cardona Gloria Y; Bernhart SH; Fillinger S; Wolz OO; Dickhöfer S; Admard J; Ossowski S; Nahnsen S; Siebert R; Weber ANR
    Front Immunol; 2021; 12():616451. PubMed ID: 34163463
    [TBL] [Abstract][Full Text] [Related]  

  • 16. More than complementing Tolls: complement-Toll-like receptor synergy and crosstalk in innate immunity and inflammation.
    Hajishengallis G; Lambris JD
    Immunol Rev; 2016 Nov; 274(1):233-244. PubMed ID: 27782328
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The hepatitis B e antigen (HBeAg) targets and suppresses activation of the toll-like receptor signaling pathway.
    Lang T; Lo C; Skinner N; Locarnini S; Visvanathan K; Mansell A
    J Hepatol; 2011 Oct; 55(4):762-9. PubMed ID: 21334391
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quercetin regulates oxidized LDL induced inflammatory changes in human PBMCs by modulating the TLR-NF-κB signaling pathway.
    Bhaskar S; Shalini V; Helen A
    Immunobiology; 2011 Mar; 216(3):367-73. PubMed ID: 20828867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alternative splicing in the NF-kappaB signaling pathway.
    Leeman JR; Gilmore TD
    Gene; 2008 Nov; 423(2):97-107. PubMed ID: 18718859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dissecting negative regulation of Toll-like receptor signaling.
    Kondo T; Kawai T; Akira S
    Trends Immunol; 2012 Sep; 33(9):449-58. PubMed ID: 22721918
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.